title: Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech Republic.
authors.affiliation: VALUE OUTCOMES, s. r. o., Prague, Czech Republic.
authors.forename: T
authors.initials: T
authors.lastname: Mlcoch
authors.affiliation: VALUE OUTCOMES, Prague, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Klimes
authors.affiliation: VALUE OUTCOMES, Prague, Czech Republic.
authors.forename: K
authors.initials: K
authors.lastname: Kruntoradova
authors.affiliation: VALUE OUTCOMES, s. r. o., Prague, Czech Republic.
authors.forename: M
authors.initials: M
authors.lastname: Mandelikova
authors.affiliation: VALUE OUTCOMES, Prague, Czech Republic.
authors.forename: T
authors.initials: T
authors.lastname: Dolezal